Sfoglia per Rivista
Leptin receptors on human hepatic stellate cells mediate the expression of proangiogenic cytokines via activation of hypoxia inducile factor
2005-01-01 Aleffi S; Bertolani C; Novo E; Parola M; Marra F.
Liver cirrhosis and intrahepatic rennin-angiotensin system: a reappraisal.
2010-01-01 Sansoé G; Aragno M; Tomasinelli CE; Mastrocola R; Parola M
Liver production of Endothelin-1 in experimental liver cirrhosis is decreased after neutral endopeptidase system (EC3.4.24.11) inhibition: physiopathological implications
2006-01-01 Sansoè GC; Aragno M; Mastrocola R; Rosina F; Smedile A; Rizzetto M; Parola M.
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience
2014-01-01 Risso, Alessandro; Tandoi, Francesco; Martini, Silvia; Romagnoli, Renato; Salizzoni, Mauro
Local hypothyroidism favours the progression of rat preneoplastic lesions to HCC.
2014-01-01 Frau C;Loi R;Petrelli A;Perra A;Menegon S;Kowalik MA;Pinna S;Leoni VP;Fornari F;Gramantieri L;Ledda-Columbano GM;Giordano S;Columbano A
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
1993-01-01 SARACCO G ;ROSINA F ;ABATE ML ;CHIANDUSSI L ;GALLO V ;CERUTTI E ;DI NAPOLI A ;SOLINAS A ;DEPLANO A ;TOCCO A
The long-term impact of baseline PNPLA3 genotyping in patients with NAFLD. A longitudinal multicentre study
2019-01-01 Ramy Younes, Salvatore Petta, Luca Miele, Chiara Rosso, Olivier Govaree, Grazia Pennisi, Paolo Francione, Anna Ludovica Francanzani, Luca Valenti, Ann Daly, Quentin Anstee, Elisabetta Bugianesi
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients
2006-01-01 RAIMONDO G; BRUNETTO MR; PONTISSO P; SMEDILE A; MAINA AM; SAITTA C; SQUADRITO G; TONO N
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study
2023-01-01 Lee, Jenny; Westphal, Max; Vali, Yasaman; Boursier, Jerome; Petta, Salvatorre; Ostroff, Rachel; Alexander, Leigh; Chen, Yu; Fournier, Celine; Geier, Andreas; Francque, Sven; Wonders, Kristy; Tiniakos, Dina; Bedossa, Pierre; Allison, Mike; Papatheodoridis, Georgios; Cortez-Pinto, Helena; Pais, Raluca; Dufour, Jean-Francois; Leeming, Diana Julie; Harrison, Stephen; Cobbold, Jeremy; Holleboom, Adriaan G; Yki-Järvinen, Hannele; Crespo, Javier; Ekstedt, Mattias; Aithal, Guruprasad P; Bugianesi, Elisabetta; Romero-Gomez, Manuel; Torstenson, Richard; Karsdal, Morten; Yunis, Carla; Schattenberg, Jörn M; Schuppan, Detlef; Ratziu, Vlad; Brass, Clifford; Duffin, Kevin; Zwinderman, Koos; Pavlides, Michael; Anstee, Quentin M; Bossuyt, Patrick M
MAGIC-FACTOR, A PARTIAL AGONIST OF MET, ACTS AS A SAFE HEPATOTROPHIC CYTOKINE
2011-01-01 T. Takahara; K. Kawai; T. Sugiyama; M. Asahi; P. Michieli
Matabolomic analysis identifies new biomarkers of liver damage in NAFLD
2014-01-01 Ester Vanni; Chiara Rosso; Lavinia Mezzabotta; Chiara Saponaro; Melania Gaggini; Roberto Gambino; Ramy Ibrahim Kamal Jouness; Francesca Saba; Emma Buzzigoli; Fabrizia Carli; Gian Paolo Caviglia; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto; Maurizio Cassader; Amalia Gastaldelli; Elisabetta Bugianesi
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B
2017-01-01 Thabet K.; Chan H.L.Y.; Petta S.; Mangia A.; Berg T.; Boonstra A.; Brouwer W.P.; Abate M.L.; Wong V.W.-S.; Nazmy M.; Fischer J.; Liddle C.; George J.; Eslam M.
Metabolic Syndrome and Severity of Fibrosis in Nonalcoholic Fatty Liver Disease: An Age-Dependent Risk Profiling Study
2016-01-01 Petta, Salvatore; Eslam, Mohammed; Valenti, Luca; Bugianesi, Elisabetta; Barbara, Marco; Cammà, Calogero; Porzio, Marianna; Rosso, Chiara; Fargion, Silvia; George, Jacob; Craxì, Antonio
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis
2008-01-01 Takahara T; Xue F; Mazzone M; Yata Y; Nonome K; Kanayama M; Kawai K; Pisacane AM; Takahara S; Li XK; Comoglio PM; Sugiyama T; Michieli P
MicroRNA/gene profiling unveils early molecular changes and NRF2 activation in a rat model recapitulating human HCC.
2014-01-01 Petrelli A;Perra A;Cora D;Sulas P;Menegon S;Manca C;Migliore C;Kowalik MA;Ledda-Columbano GM;Giordano S;Columbano A
MicroRNAs: New tools for diagnosis, prognosis and therapy in hepatocellular carcinoma?
2013-01-01 Giordano S;Columbano A
MiRs*: Innocent bystanders only?
2016-01-01 Giordano, Silvia
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy.
1999-01-01 SAKAMOTO T.; LIU Z.; MURASE N.; EZURE T.; YOKOMURO S.; V. POLI; DEMETRIS A.J.
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort
2017-01-01 Kondili L.A.; Romano F.; Rolli F.R.; Ruggeri M.; Rosato S.; Brunetto M.R.; Zignego A.L.; Ciancio A.; Di Leo A.; Raimondo G.; Ferrari C.; Taliani G.; Borgia G.; Santantonio T.A.; Blanc P.; Gaeta G.B.; Gasbarrini A.; Chessa L.; Erne E.M.; Villa E.; Ieluzzi D.; Russo F.P.; Andreone P.; Vinci M.; Coppola C.; Chemello L.; Madonia S.; Verucchi G.; Persico M.; Zuin M.; Puoti M.; Alberti A.; Nardone G.; Massari M.; Montalto G.; Foti G.; Rumi M.G.; Quaranta M.G.; Cicchetti A.; Craxi A.; Vella S.
Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis.
1994-01-01 ARRIGONI A ;GINDRO T ;AIMO G ;CAPPELLO N ;MELONI A ;BENEDETTI P ;MOLINO GP ;VERME G ;RIZZETTO M
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Leptin receptors on human hepatic stellate cells mediate the expression of proangiogenic cytokines via activation of hypoxia inducile factor | 2005 | Aleffi S; Bertolani C; Novo E; Parola M; Marra F. | |
Liver cirrhosis and intrahepatic rennin-angiotensin system: a reappraisal. | 2010 | Sansoé G; Aragno M; Tomasinelli CE; Mastrocola R; Parola M | |
Liver production of Endothelin-1 in experimental liver cirrhosis is decreased after neutral endopeptidase system (EC3.4.24.11) inhibition: physiopathological implications | 2006 | Sansoè GC; Aragno M; Mastrocola R; Rosina F; Smedile A; Rizzetto M; Parola M. | |
Liver transplantation for patients with HCV-related end-stage liver disease and undetectable HCV-RNA: the Turin Centre experience | 2014 | Risso, Alessandro; Tandoi, Francesco; Martini, Silvia; Romagnoli, Renato; Salizzoni, Mauro | |
Local hypothyroidism favours the progression of rat preneoplastic lesions to HCC. | 2014 | Frau C;Loi R;Petrelli A;Perra A;Menegon S;Kowalik MA;Pinna S;Leoni VP;Fornari F;Gramantieri L;Ledda-Columbano GM;Giordano S;Columbano A | |
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. | 1993 | SARACCO G ;ROSINA F ;ABATE ML ;CHIANDUSSI L ;GALLO V ;CERUTTI E ;DI NAPOLI A ;SOLINAS A ;DEPLANO A ;TOCCO A | |
The long-term impact of baseline PNPLA3 genotyping in patients with NAFLD. A longitudinal multicentre study | 2019 | Ramy Younes, Salvatore Petta, Luca Miele, Chiara Rosso, Olivier Govaree, Grazia Pennisi, Paolo Francione, Anna Ludovica Francanzani, Luca Valenti, Ann Daly, Quentin Anstee, Elisabetta Bugianesi | |
Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients | 2006 | RAIMONDO G; BRUNETTO MR; PONTISSO P; SMEDILE A; MAINA AM; SAITTA C; SQUADRITO G; TONO N | |
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study | 2023 | Lee, Jenny; Westphal, Max; Vali, Yasaman; Boursier, Jerome; Petta, Salvatorre; Ostroff, Rachel; Alexander, Leigh; Chen, Yu; Fournier, Celine; Geier, Andreas; Francque, Sven; Wonders, Kristy; Tiniakos, Dina; Bedossa, Pierre; Allison, Mike; Papatheodoridis, Georgios; Cortez-Pinto, Helena; Pais, Raluca; Dufour, Jean-Francois; Leeming, Diana Julie; Harrison, Stephen; Cobbold, Jeremy; Holleboom, Adriaan G; Yki-Järvinen, Hannele; Crespo, Javier; Ekstedt, Mattias; Aithal, Guruprasad P; Bugianesi, Elisabetta; Romero-Gomez, Manuel; Torstenson, Richard; Karsdal, Morten; Yunis, Carla; Schattenberg, Jörn M; Schuppan, Detlef; Ratziu, Vlad; Brass, Clifford; Duffin, Kevin; Zwinderman, Koos; Pavlides, Michael; Anstee, Quentin M; Bossuyt, Patrick M | |
MAGIC-FACTOR, A PARTIAL AGONIST OF MET, ACTS AS A SAFE HEPATOTROPHIC CYTOKINE | 2011 | T. Takahara; K. Kawai; T. Sugiyama; M. Asahi; P. Michieli | |
Matabolomic analysis identifies new biomarkers of liver damage in NAFLD | 2014 | Ester Vanni; Chiara Rosso; Lavinia Mezzabotta; Chiara Saponaro; Melania Gaggini; Roberto Gambino; Ramy Ibrahim Kamal Jouness; Francesca Saba; Emma Buzzigoli; Fabrizia Carli; Gian Paolo Caviglia; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto; Maurizio Cassader; Amalia Gastaldelli; Elisabetta Bugianesi | |
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B | 2017 | Thabet K.; Chan H.L.Y.; Petta S.; Mangia A.; Berg T.; Boonstra A.; Brouwer W.P.; Abate M.L.; Wong V.W.-S.; Nazmy M.; Fischer J.; Liddle C.; George J.; Eslam M. | |
Metabolic Syndrome and Severity of Fibrosis in Nonalcoholic Fatty Liver Disease: An Age-Dependent Risk Profiling Study | 2016 | Petta, Salvatore; Eslam, Mohammed; Valenti, Luca; Bugianesi, Elisabetta; Barbara, Marco; Cammà, Calogero; Porzio, Marianna; Rosso, Chiara; Fargion, Silvia; George, Jacob; Craxì, Antonio | |
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis | 2008 | Takahara T; Xue F; Mazzone M; Yata Y; Nonome K; Kanayama M; Kawai K; Pisacane AM; Takahara S; Li XK; Comoglio PM; Sugiyama T; Michieli P | |
MicroRNA/gene profiling unveils early molecular changes and NRF2 activation in a rat model recapitulating human HCC. | 2014 | Petrelli A;Perra A;Cora D;Sulas P;Menegon S;Manca C;Migliore C;Kowalik MA;Ledda-Columbano GM;Giordano S;Columbano A | |
MicroRNAs: New tools for diagnosis, prognosis and therapy in hepatocellular carcinoma? | 2013 | Giordano S;Columbano A | |
MiRs*: Innocent bystanders only? | 2016 | Giordano, Silvia | |
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. | 1999 | SAKAMOTO T.; LIU Z.; MURASE N.; EZURE T.; YOKOMURO S.; V. POLI; DEMETRIS A.J. | |
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort | 2017 | Kondili L.A.; Romano F.; Rolli F.R.; Ruggeri M.; Rosato S.; Brunetto M.R.; Zignego A.L.; Ciancio A.; Di Leo A.; Raimondo G.; Ferrari C.; Taliani G.; Borgia G.; Santantonio T.A.; Blanc P.; Gaeta G.B.; Gasbarrini A.; Chessa L.; Erne E.M.; Villa E.; Ieluzzi D.; Russo F.P.; Andreone P.; Vinci M.; Coppola C.; Chemello L.; Madonia S.; Verucchi G.; Persico M.; Zuin M.; Puoti M.; Alberti A.; Nardone G.; Massari M.; Montalto G.; Foti G.; Rumi M.G.; Quaranta M.G.; Cicchetti A.; Craxi A.; Vella S. | |
Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis. | 1994 | ARRIGONI A ;GINDRO T ;AIMO G ;CAPPELLO N ;MELONI A ;BENEDETTI P ;MOLINO GP ;VERME G ;RIZZETTO M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile